Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab

被引：1
作者：
Matsumura, Takashi [1 ]
Tsuchihashi, Kenji [1 ]
Yamamoto, Takeo [2 ]
Jinnouchi, Fumiaki [1 ]
Kusano, Wataru [1 ]
Kusumoto, Yota [1 ]
Arimizu, Kohei [1 ]
Ohmura, Hirofumi [3 ]
Kuma, Yuki [4 ]
Moriyama, Shohei [1 ]
Yamaguchi, Kyoko [5 ]
Ito, Mamoru [1 ]
Isobe, Taichi [3 ]
Ariyama, Hiroshi [1 ]
Oda, Yoshinao [2 ]
Akashi, Koichi [1 ]
Baba, Eishi [3 ]
机构：
[1] Kyushu Univ Hosp, Dept Hematol Oncol & Cardiovasc Med, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Kyushu, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Comprehens Oncol, Kyushu, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan
[5] Kyushu Univ, Grad Sch Med Sci, Dept Med Educ, Fukuoka, Japan
来源：
INTERNAL MEDICINE | 2024年
关键词：
Lymph proliferative disorders; EBV; Pembrolizumab; Immune checkpoint inhibitor; RHEUMATOID-ARTHRITIS; METHOTREXATE; LYMPHOMA;
D O I：
10.2169/internalmedicine.3743-24
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 75-year-old man diagnosed with esophageal cancer and lung metastasis received a combination of fluorouracil, cisplatin, and pembrolizumab. During pembrolizumab maintenance therapy, lymphoproliferative lesions at the lips and mouth and multiple lymph node swellings appeared. Histologically, Epstein-Barr virus (EBV)-encoded RNA was positive, and EBV-DNA was detected in the blood. The patient was diagnosed with other iatrogenic immunodeficiency-associated lymph proliferative disorders (OIIA-LPDs) related to EBV activation induced by pembrolizumab. Rituximab was administered, resulting in the improvement of the OIIA-LPD. The emergence of an OIIA-LPD merits close attention in patients receiving immune checkpoint inhibitors.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Cutaneous Lymphoproliferative Disorder Complicating Infectious Mononucleosis in an Immunosuppressed Patient
    Owen, Cindy England
    Callen, Jeffrey P.
    Bahrami, Soon
    PEDIATRIC DERMATOLOGY, 2011, 28 (02) : 149 - 155
  • [32] Pembrolizumab Combined with Chemotherapy for the Treatment of locally Advanced Esophageal Cancer
    Han, KaiHong
    Xie, ShaoNan
    Liu, QingYi
    Cheng, JingGe
    Han, YaQing
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 : 163 - 171
  • [33] Narrative review of pembrolizumab for the treatment of esophageal cancer: evidence and outlook
    Jin, Zixian
    Shen, Jianfei
    Wang, Chunguo
    Chen, Dong
    Zhang, Bo
    Zhang, Jian
    Ajani, Jaffer A.
    Bennouna, Jaafar
    Chao, Joseph
    Yoon, Harry H.
    Zhu, Hongyu
    Ruan, Yuhang
    Zhu, Chengchu
    Xu, Anyi
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (14)
  • [34] AlemtuzumabFirst report of lymphoproliferative disorder in an elderly patient: case report
    Reactions Weekly, 2004, 990 (1) : 6 - 6
  • [35] Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report
    Paul, Petitgas
    Mathieu, Lesouhaitier
    Sarrah, Boukthir
    Vincent, Cattoir
    Pierre, Tattevin
    Francois, Benezit
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [36] Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate
    Saito, Shuntaro
    Kaneko, Yuko
    Yamaoka, Kunihiro
    Tokuhira, Michihide
    Takeuchi, Tsutomu
    RHEUMATOLOGY, 2017, 56 (06) : 940 - 946
  • [37] A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab
    Carlos, Giuliana
    Anforth, Rachael
    Chou, Shaun
    Clements, Arthur
    Fernandez-Penas, Pablo
    MELANOMA RESEARCH, 2015, 25 (03) : 265 - 268
  • [38] Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report
    Paul Petitgas
    Mathieu Lesouhaitier
    Sarrah Boukthir
    Vincent Cattoir
    Pierre Tattevin
    François Bénézit
    BMC Infectious Diseases, 22
  • [39] Long-term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
    Uchida, Tsuyoshi
    Matsubara, Hirochika
    Muto, Mamoru
    Sasanuma, Harunobu
    Sugimura, Saya
    Onuki, Yuichiro
    Nakajima, Hiroyuki
    CLINICAL CASE REPORTS, 2022, 10 (12):
  • [40] Primary Intraocular Methotrexate-related Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis Undergoing Long-term Methotrexate Therapy
    Sone, Kumiko
    Usui, Yoshihiko
    Fujii, Keiko
    Goto, Hiroshi
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (03) : 456 - 459
12345